MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
OpGen Total Liabilities 2011-2026 | OPGN
Annual Total Liabilities OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.48 M | 13.4 M | 18.2 M | 30.4 M | 28.6 M | 6.13 M | 5.64 M | 5.22 M | 5.82 M | 6.27 M | 10.7 M | 4.99 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.4 M | 2.48 M | 11.5 M |
Quarterly Total Liabilities OpGen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.48 M | 2.58 M | 2.36 M | 2.48 M | 2.48 M | 14.5 M | - | 13.4 M | 15.5 M | 15.6 M | 17.3 M | 18.2 M | 19 M | 21.4 M | 30.1 M | 30.4 M | 29 M | 28.8 M | 29.1 M | 28.6 M | 28.6 M | 28.6 M | 28.6 M | 6.13 M | 6.13 M | 6.13 M | 6.13 M | 5.64 M | 5.64 M | 5.64 M | 5.64 M | 5.22 M | 5.22 M | 5.22 M | 5.22 M | 5.82 M | 5.82 M | 5.82 M | 5.82 M | 6.27 M | 6.27 M | 6.27 M | 6.27 M | 6.16 M | 6.16 M | 6.16 M | 6.16 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 30.4 M | 2.36 M | 12 M |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
108 M | $ 20.47 | 2.17 % | $ 593 M |  USA |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 17.3 | 5.42 % | $ 523 M | USA |
 |
Guardant Health
GH
|
2.11 B | $ 119.81 | 4.21 % | $ 15 B | USA |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 114.96 | -0.11 % | $ 9.48 B |  Irlanda |
 |
Agilent Technologies
A
|
5.32 B | $ 113.85 | 0.11 % | $ 34.6 B | USA |
 |
Celcuity
CELC
|
366 M | $ 139.6 | -0.52 % | $ 6.53 B | USA |
 |
Co-Diagnostics
CODX
|
4.11 M | $ 4.01 | 67.99 % | $ 5.33 M | USA |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
110 M | $ 22.14 | 4.68 % | $ 1.18 B | USA |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
1.14 B | $ 94.97 | -1.17 % | $ 6.41 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
11.5 M | $ 1.8 | - | $ 7.96 M | USA |
 |
Illumina
ILMN
|
2.7 B | $ 143.09 | 0.82 % | $ 22.8 B | USA |
 |
Medpace Holdings
MEDP
|
1.52 B | $ 422.06 | 0.05 % | $ 12.2 B | USA |
 |
Mettler-Toledo International
MTD
|
3.74 B | $ 1 084.7 | 0.14 % | $ 22.4 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Natera
NTRA
|
689 M | $ 207.46 | 1.24 % | $ 20.4 B | USA |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Personalis
PSNL
|
73 M | $ 8.51 | 7.04 % | $ 759 M | USA |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 157.83 | 1.11 % | $ 7.82 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
523 M | $ 8.98 | 0.9 % | $ 1.15 B | USA |
 |
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
121 M | $ 19.1 | -0.86 % | $ 428 M | USA |
 |
Myriad Genetics
MYGN
|
339 M | $ 3.8 | -0.39 % | $ 352 M | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
Thermo Fisher Scientific
TMO
|
28.7 B | $ 450.38 | -0.27 % | $ 170 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
16 B | $ 26.84 | 0.41 % | $ 25.5 B |  Niderland |
 |
Senseonics Holdings
SENS
|
65.2 M | $ 5.79 | 1.4 % | $ 242 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
114 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.84 M | $ 2.42 | 2.98 % | $ 5.56 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 253.97 | -1.3 % | $ 21.1 B | USA |
 |
Waters Corporation
WAT
|
2.52 B | $ 339.14 | -0.61 % | $ 20.2 B | USA |
 |
Twist Bioscience Corporation
TWST
|
169 M | $ 53.72 | 0.11 % | $ 3.21 B | USA |
 |
Trinity Biotech plc
TRIB
|
138 M | $ 0.62 | 1.89 % | $ 223 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
Exagen
XGN
|
40.6 M | $ 4.11 | 7.31 % | $ 88.6 M | USA |
 |
Neogen Corporation
NEOG
|
1.37 B | $ 8.52 | -3.57 % | $ 1.85 B | USA |